Search PDMR transactions

Notifier
Name of person with notification obligation
Viktor Siewertz
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Viktor Siewertz
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
IRLAB Therapeutics AB
Issuer´s LEI code
549300JAT34LHEI0DH60
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share IRLAB Therapeutics AB ser. A SE0012675361 Disposal 40 Quantity 35.20 SEK 29/08/2022 NASDAQ STOCKHOLM AB
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 40 Quantity 35.50 SEK 30/08/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
IRLAB Therapeutics AB ser. A SE0012675361 Disposal 29/08/2022 NASDAQ STOCKHOLM AB 40 (Quantity) 35.20 SEK
IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 30/08/2022 NASDAQ STOCKHOLM AB 40 (Quantity) 35.50 SEK
<< Back